v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Aug. 28, 2026
Aug. 29, 2025
Aug. 30, 2024
Cash flows from operating activities      
Net income (loss) $ 185,788 $ 28,835 $ (49,933)
Net loss from discontinued operations 0 0 (8,148)
Net income (loss) from continuing operations 185,788 28,835 (41,785)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used for) operating activities:      
Depreciation expense and amortization of intangible assets 50,176 56,216 65,716
Amortization of debt issuance costs 2,728 3,493 3,724
Stock-based compensation expense 31,815 41,176 43,160
Loss on impairment of non-marketable equity investment 10,000 0 0
Impairment of goodwill 0 16,063 0
Loss on extinguishment of debt 0 2,908 22,763
Inducement expense related to the conversion of the 2029 and 2030 Notes 33,248 0 0
Gain on disposition of equity investment (30,942) 0 0
Deferred income taxes, net (62,660) (14,112) (11,042)
Other 1,969 (2,293) (2,689)
Changes in operating assets and liabilities:      
Accounts receivable (including related party balances of $683, $— , and $— as of August 28, 2026, August 29, 2025, and August 30, 2024, respectively) (488,360) (56,160) (32,495)
Inventories (493,603) (101,610) 23,765
Other assets 964 7,653 9,098
Accounts payable and accrued expenses and other liabilities 606,963 131,014 54,306
Payment of acquisition-related contingent consideration 0 0 (29,000)
Net cash provided by (used for) operating activities from continuing operations (151,914) 113,183 105,521
Net cash used for operating activities from discontinued operations 0 (4,099) (28,336)
Net cash provided by (used for) operating activities (151,914) 109,084 77,185
Cash flows from investing activities      
Capital expenditures and deposits on equipment (11,569) (9,012) (19,424)
Proceeds from sales and maturities of investment securities 0 66,361 39,395
Purchases of held-to-maturity investment securities 0 (59,066) (19,503)
Purchases of non-marketable investments 0 0 (11,000)
Proceeds from disposition of equity investments 71,752 0 0
Other (2,093) (1,660) (1,272)
Net cash provided by (used for) investing activities from continuing operations 58,090 (3,377) (11,804)
Net cash provided by investing activities from discontinued operations 0 28,350 119,389
Net cash provided by (used for) investing activities 58,090 24,973 107,585
Cash flows from financing activities      
Repayments of debt (315,454) (300,015) (351,337)
Payments to acquire common stock (74,427) (52,320) (21,309)
Payment of acquisition-related contingent consideration 0 0 (21,000)
Net cash paid for settlement and purchase of capped calls (49,125) 0 (16,300)
Distribution to noncontrolling interest 0 0 (1,470)
Proceeds from debt, net of lender debt issuance costs 736,500 0 192,694
Payment of third-party debt issuance costs (1,341) 0 0
Proceeds from issuance of common stock 10,358 8,804 9,809
Proceeds from restricted cash advances 93,000 0 0
Payment of preferred stock cash dividends (12,233) (7,860) 0
Repayments of borrowings under line of credit (100,000) 0 0
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 191,182 0
Proceeds from borrowing under line of credit 0 100,000 0
Fees paid for revolving line of credit financing 0 (3,255) 0
Other 0 0 (582)
Net cash provided by (used for) financing activities from continuing operations 287,278 (63,464) (209,495)
Net cash used for financing activities from discontinued operations 0 0 (606)
Net cash provided by (used for) financing activities 287,278 (63,464) (210,101)
Effect of changes in currency exchange rates 0 0 (1,256)
Net increase in cash, cash equivalents and restricted cash 193,454 70,593 (26,587)
Cash, cash equivalents and restricted cash at beginning of period 454,070 383,477 410,064
Cash, cash equivalents and restricted cash at end of period $ 647,524 $ 454,070 $ 383,477